Louisiana Revised Statutes 40:976.1 – Chemical precursor; recordkeeping requirements
Terms Used In Louisiana Revised Statutes 40:976.1
- delivery: means the transfer of a controlled dangerous substance whether or not there exists an agency relationship. See Louisiana Revised Statutes 40:961
- Drug: means :
(a) Articles recognized in the official United States Pharmacopoeia, official Homeopathic Pharmacopoeia of the United States, or official National Formulary, or any supplement to any of them. See Louisiana Revised Statutes 40:961
- Isomers: refers to optical isomers and/or stereoisomers and mixtures thereof, unless specifically excepted in this Part. See Louisiana Revised Statutes 40:961
- Person: includes any institution whether public or private, hospitals or clinics operated by the state or any of its political subdivisions, and any corporation, association, partnership, or one or more individuals. See Louisiana Revised Statutes 40:961
- Prescription: means a written request for a drug or therapeutic aid issued by a licensed physician, dentist, veterinarian, osteopath, or podiatrist for a legitimate medical purpose, for the purpose of correcting a physical, mental, or bodily ailment, and acting in good faith in the usual course of his professional practice. See Louisiana Revised Statutes 40:961
- Secretary: means the secretary of the Louisiana Department of Health or his successor. See Louisiana Revised Statutes 40:961
- State: means the state of Louisiana. See Louisiana Revised Statutes 40:961
A. A manufacturer, wholesaler, retailer, or other person who sells, transfers, or otherwise furnishes any of the following precursor substances shall make an accurate and legible record of the transaction and maintain the record for a period of at least five years after the date of the transaction:
(1) Methylamine
(2) Ethylamine
(3) D-lysergic acid
(4) Ergotamine tartrate
(5) Diethyl malonate
(6) Malonic acid
(7) Ethyl malonate
(8) Barbituric acid
(9) Piperidine
(10) N-acetylanthranilic acid
(11) Pyrrolidine
(12) Phenylacetic acid
(13) Anthranilic acid
(14) Morpholine
(15) Ephedrine
(16) Pseudoephedrine or norpseudoephedrine
(17) Phenylpropanolamine
(18) Acetic anhydride
(19) Anthranilic acid, its esters and its salts
(20) Benzaldehyde
(21) Benzyl chloride
(22) Benzyl cyanide
(23) Ergonovine and its salts
(24) Hydriodic acid
(25) Isosafrole
(26) 3,4-methylenedioxyphenyl-2-propanone
(27) N-ethylephedrine, its salts, optical isomers, and salts of optical isomers
(28) N-ethylpseudoephedrine, its salts, optical isomers, and salts of optical isomers
(29) N-methylephedrine, its salts, optical isomers, and salts of optical isomers
(30) N-methylpseudoephedrine, its salts, optical isomers, and salts of optical isomers
(31) Nitroethane
(32) 1-phenyl-1-chloro-2-methylaminopropanone (chloroephedrine; chloropseudoephedrine), their salts, optical isomers, and salts of optical isomers
(33) Phenyl-2-propanone
(34) Piperonal
(35) Propionic anhydride
(36) Safrole
(37) Thionylchloride
B.(1) Before selling, transferring, or otherwise furnishing to a person in this state a precursor substance designated in Subsection A of this Section, a manufacturer, wholesaler, retailer, or other person shall obtain from the buyer or recipient not representing a business the following information:
(a) The recipient’s driver’s license number or other personal identification certificate number, date of birth, and residential or mailing address, other than post office box number. This information shall be obtained from a driver’s license or other personal identification card issued by the Department of Public Safety and Corrections that contains a photograph of the recipient.
(b) The year, state, and number of the motor vehicle license of the motor vehicle owned or operated by the recipient.
(c) A complete description of how the substance is to be used.
(d) The recipient’s signature.
(2) Before selling, transferring, or otherwise furnishing to a person in this state a precursor substance designated in Subsection A of this Section, a manufacturer, wholesaler, retailer, or other person shall obtain from the buyer or recipient representing a business the following information:
(a) A letter of authorization from the business that includes the business license or comptroller tax identification number, address, area code, and telephone number and a complete description of how the substance is to be used.
(b) The signature of the recipient.
(3) For any recipient, the seller, manufacturer, or retailer shall sign as a witness to the signature and identification of the recipient.
C. Except as provided by Subsection E of this Section, a manufacturer, wholesaler, retailer, or other person who sells, transfers, or otherwise furnishes to a person in this state a precursor substance designated in Subsection A of this Section shall, at least twenty-one days before the delivery of the substance, submit a report of the transaction on a form obtained from the deputy secretary that includes the information required by Subsection B of this Section.
D. The deputy secretary shall supply to a manufacturer, wholesaler, retailer, or other person who sells, transfers, or otherwise furnishes a precursor substance subject to Subsection A of this Section a form for the submission of:
(1) The report required by Subsection C of this Section.
(2) The name and measured amount of the precursor substance, delivered.
(3) Any other information required by the deputy secretary.
E. The deputy secretary shall require a manufacturer, wholesaler, retailer, or other person to submit a comprehensive monthly report instead of the report required by Subsection C of this Section if the deputy secretary determines either of the following:
(1) That there is a pattern of regular supply and purchase of the substance between the furnisher and the recipient.
(2) That the recipient has established a record of utilization of the substance solely for a lawful purpose.
F. A manufacturer, wholesaler, retailer, or other person who received from a source outside this state a substance designated in Subsection A of this Section or who discovers a loss or theft of a substance designated in Subsection A of this Section shall submit a report of the transaction to the deputy secretary in accordance with rules adopted pursuant to administrative procedure, and shall include in the report any difference between the amount of the substance actually received and the amount of the substance shipped according to the shipping statement or invoice or the amount of the loss or theft.
G. A report required under Subsection F of this Section shall:
(1) Be made not later than the third day after the date that the manufacturer, wholesaler, retailer, or other person learns of the discrepancy, loss, or theft.
(2) If the discrepancy, loss, or theft occurred during a shipment of the substance, include the name of the common carrier or person who transported the substance and the date that the substance was shipped.
H. The provisions of this Section shall not apply to the sale or transfer of a nonnarcotic product that includes a precursor substance listed in Subsection A of this Section, if the product may otherwise be sold lawfully with a prescription or over the counter without a prescription under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. § 301 et seq.) or a rule adopted thereunder.
I. Any person who violates the provisions of this Section shall be imprisoned with or without hard labor for not more than one year, and in addition may be fined not more than one thousand dollars.
Added by Acts 1989, No. 374, §1. Acts 1993, No. 994, §1; Acts 2018, No. 206, §4.